{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:03:31Z","timestamp":1778238211983,"version":"3.51.4"},"reference-count":90,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>This protocol aims to characterize patients with dual disorders (DD; comorbid major depression and schizophrenia) compared with patients with only a diagnosis of substance use disorder (SUD) and those with only a diagnosis of severe mental illness (SMI; major depression and schizophrenia), evaluating clinical and personality characteristics, circadian rhythmic functioning, genetic polymorphism and neuropsychological performance in order to obtain a clinical endophenotype of differential vulnerability for these diagnostic entities. Patients will be divided into three groups: DD (45 men with comorbid schizophrenia, 45 men and 30 women with major depression), SUD (n = 90, with a minimum of 30 women) and SMI males (45 with schizophrenia, 45 with major depression). All patients will be under treatment, with at least three months of SUD abstinence and\/or with SMI in remission or with stabilized symptoms. Outpatients of both sexes with insufficient restoration of circadian rhythmicity with SUD (n = 30) and dual depression (n = 30) will be asked to participate in a second two-month study, being alternately assigned to the condition of the chronobiological adjuvant approach to the treatment of regular hour habits and exposure to light or to the usual treatment (control). The effect of the intervention and patient compliance will be monitored with a Kronowise KW6\u00ae ambulatory device during the first two weeks of treatment and again at weeks 4 and 8 weeks. After completing the evaluation, follow-up of the clinical evolution will be carried out at 3, 6 and 12 months. This project will allow us to analyze the functional impact of DD comorbidity and to develop the first study of chronobiological therapy in the treatment of SUD and dual depression, with results transferable to the clinical setting with cost-effective recommendations for a personalized approach.<\/jats:p>","DOI":"10.3390\/jcm11071846","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T21:27:51Z","timestamp":1648416471000},"page":"1846","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protocol for Characterization of Addiction and Dual Disorders: Effectiveness of Coadjuvant Chronotherapy in Patients with Partial Response"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-3452","authenticated-orcid":false,"given":"Ana","family":"Adan","sequence":"first","affiliation":[{"name":"Department of Clinical Psychology and Psychobiology, School of Psychology, University of Barcelona, Passeig de la Vall d\u2019Hebr\u00f3n 171, 08035 Barcelona, Spain"},{"name":"Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-8974","authenticated-orcid":false,"given":"Jos\u00e9 Francisco","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Psychobiology, School of Psychology, University of M\u00e1laga, Campus de Teatinos s\/n, 29071 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of ADDISCHRONO Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Adan, A., and Torrens, M. (2021). Special Issue: Diagnosis and management of addiction and other mental disorders (dual disorders). J. Clin. Med., 10.","DOI":"10.3390\/jcm10061307"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2018.07.011","article-title":"Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990\u20132017: Systematic review and meta-analysis","volume":"191","author":"Hunt","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","article-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990\u20132014: Systematic review and meta-analysis","volume":"154","author":"Cleary","year":"2015","journal-title":"Drug Alcohol Dep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.20882\/adicciones.59","article-title":"Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services","volume":"25","author":"Arias","year":"2013","journal-title":"Adicciones"},{"key":"ref_5","unstructured":"European Monitoring Centre for Drug and Drug Addiction (2019). Comorbidity of Substance Use and Mental Disorders in Europe, EMCDDA Insights, Publications Office of the European Union."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-859X-12-32","article-title":"Definitions and drivers of relapse in patients with schizophrenia: A systematic literature review","volume":"12","author":"Olivares","year":"2013","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fpsyt.2018.00764","article-title":"Personality profile and clinical correlates of patients with substance use disorder with and without comorbid depression under treatment","volume":"9","author":"Navarro","year":"2019","journal-title":"Front. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Marquez-Arrico, J.E., Navarro, J.F., and Adan, A. (2020). Health-Related Quality of Life in male patients under treatment for substance use disorders with and without major depressive disorder: Influence in clinical course at one-year Follow-up. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103110"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.20882\/adicciones.933","article-title":"Patolog\u00eda dual: Una perspectiva europea","volume":"29","author":"Torrens","year":"2017","journal-title":"Adicciones"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.neubiorev.2010.03.004","article-title":"Circadian clock genes: Non-circadian roles in sleep, addiction, and psychiatric disorders?","volume":"34","author":"Rosenwasser","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpsychires.2017.07.007","article-title":"Sleep-wake profiles and circadian rhythms of core temperature and melatonin in young people with affective disorders","volume":"94","author":"Carpenter","year":"2017","journal-title":"J. Psychiatry Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-017-0835-5","article-title":"Chronobiological theories of mood disorders","volume":"268","author":"Zaki","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.0602425103","article-title":"The circadian basis of winter depression","volume":"103","author":"Lewy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2017.01.051","article-title":"Adolescents at clinical-high risk for Psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up","volume":"189","author":"Brietzke","year":"2017","journal-title":"Schizophr. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11682-016-9650-2","article-title":"Pineal volume and evening melatonin in young people with affective disorders","volume":"11","author":"Carpenter","year":"2017","journal-title":"Brain Imaging Behav."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11920-017-0764-z","article-title":"Circadian rhythms and substance abuse: Chronobiological considerations for the treatment of addiction","volume":"19","author":"Webb","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1503\/jpn.130247","article-title":"Ambulatory sleep-wake patterns and variability in young people with emerging mental disorders","volume":"40","author":"Robillard","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5720842","DOI":"10.1155\/2017\/5720842","article-title":"Neural mechanisms of circadian regulation of neural and drug reward","volume":"2017","author":"DePoy","year":"2017","journal-title":"Neural Plast."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.biopsych.2017.11.035","article-title":"Impact of sleep and circadian rhythms on addiction vulnerability in adolescents","volume":"83","author":"Logan","year":"2018","journal-title":"Biol. Pychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15027","DOI":"10.1038\/s41598-018-33195-3","article-title":"Circadian monitoring as an aging predictor","volume":"8","author":"Madrid","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fpsyt.2018.00373","article-title":"Circadian rhythmic characteristics in men with substance use disorder under treatment. Influence of age of onset and duration of abstinence","volume":"9","author":"Capella","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/07420528.2016.1223092","article-title":"Circadian rhythmicity in substance use disorder male patients with and without comorbid depression under ambulatory and therapeutic community treatment","volume":"33","author":"Capella","year":"2016","journal-title":"Chronobiol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jsr.12371","article-title":"The two-process model of sleep regulation: A reappraisal","volume":"25","author":"Daan","year":"2016","journal-title":"J. Sleep Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40246-015-0033-3","article-title":"Success stories in genomic medicine from resource-limited countries","volume":"18","author":"Mitropoulos","year":"2015","journal-title":"Hum. Genom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4062\/biomolther.2017.131","article-title":"Neurobiological functions of the period circadian clock 2 gene (Per2)","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.smrv.2017.10.008","article-title":"Phenotyping of PER3 variants reveals widespread effects on circadian preference, sleep regulation, and health","volume":"40","author":"Archer","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2013.08.016","article-title":"A novel association of two non-synonymous polymorphisms in Per2 and Per3 genes with specific diurnal preference subscales","volume":"553","author":"Ojeda","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fpsyt.2020.00038","article-title":"Association between BDNF gene variant Rs6265 and the severity of depression in antidepressant treatment-free depressed patients","volume":"11","author":"Losenkov","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"662407","DOI":"10.3389\/fpsyt.2021.662407","article-title":"BDNF as a biomarker of cognition in schizophrenia\/psychosis: An updated review","volume":"12","author":"Nieto","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/alcalc\/agu040","article-title":"BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia","volume":"49","author":"Cheah","year":"2014","journal-title":"Alcohol Alcohol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.schres.2015.08.031","article-title":"No association between ApoE and schizophrenia: Evidence of systematic review and updated meta-analysis","volume":"169","author":"Genis","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2013.12.005","article-title":"A functional polymorphism in the promoter region of MAOA gene is associated with sleepiness in healthy subjects","volume":"337","author":"Ojeda","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2018.02.063","article-title":"Analysis of promotor polymorphism in monoamine oxidase A (MAOA) gene in completed suicide on Slovenian population","volume":"673","author":"Ursic","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.euroneuro.2015.01.007","article-title":"Cognition as a target in schizophrenia, bipolar disorder and depression","volume":"25","author":"Vieta","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiological advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13803395.2016.1196165","article-title":"Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes in abstinence","volume":"39","author":"Schmidt","year":"2017","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.schres.2013.03.001","article-title":"Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study","volume":"147","author":"Wobrock","year":"2013","journal-title":"Schizophr. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fpsyg.2016.00979","article-title":"Unraveling executive funtioning in dual diagnosis","volume":"7","author":"Duijkers","year":"2016","journal-title":"Front. Psychol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jad.2015.03.024","article-title":"Systematic review of neurocognition in people with co-occurring alcohol misuse and depression","volume":"179","author":"Hunt","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12038","DOI":"10.1038\/srep12038","article-title":"Neuropsychological performance in polyconsumer men under treatment. Influence of age of onset of substance use","volume":"5","author":"Capella","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pnpbp.2012.10.016","article-title":"Neuropsychological functioning and age-related changes in schizophrenia and\/or cocaine dependence","volume":"40","author":"Benaiges","year":"2013","journal-title":"Prog. Neuropsychopharm. Biol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hup.2279","article-title":"Executive functioning in individuals with schizophrenia and\/or cocaine dependence","volume":"28","author":"Benaiges","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neubiorev.2017.01.038","article-title":"Neurobiological underpinnings and modulating factors in psychotic disorders with a comorbid substance use disorder: A systematic review","volume":"75","author":"Adan","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Adan, A., Capella, M.M., Prat, G., Forero, D.A., L\u00f3pez-Vera, S., and Navarro, J.F. (2017). Executive functioning in males with schizophrenia and substance use disorders. Influence of lifetime suicide attempts. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169943"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2016.01.061","article-title":"Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity","volume":"237","author":"Prat","year":"2016","journal-title":"Psychiatry Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.psychres.2015.05.059","article-title":"Personality in male patients with substance use disorder and\/or severe mental illness","volume":"228","author":"Adan","year":"2015","journal-title":"Psychiatry Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3109\/07420528.2012.719971","article-title":"Circadian typology: A comprehensive review","volume":"29","author":"Adan","year":"2012","journal-title":"Chronobiol. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.paid.2016.03.028","article-title":"Personality in patients with substance use disorders according to the co-occurring severe mental illness: A study using the Alternative Five Factor Model","volume":"97","author":"Adan","year":"2016","journal-title":"Pers. Individ. Differ."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s40429-016-0127-6","article-title":"Personality-targeted interventions for substance use and misuse","volume":"3","author":"Conrod","year":"2016","journal-title":"Curr. Addict. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/15504263.2018.1512727","article-title":"Precision psychiatry and dual disorders","volume":"14","author":"Szerman","year":"2019","journal-title":"J. Dual Diagn."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11920-016-0712-3","article-title":"Social rhythm therapies for mood disorders: An update","volume":"18","author":"Haynes","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-0327(95)00081-X","article-title":"\u201cNatural\u201d light treatment of seasonal affective disorder","volume":"37","author":"Graw","year":"1996","journal-title":"J. Affect. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.4088\/JCP.14com09644","article-title":"A breakthrouggh treatment for major depression","volume":"76","author":"Kripke","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.smrv.2015.08.009","article-title":"The effects of light therapy on sleep problems: A systematic review and meta-analysis","volume":"29","author":"Meijer","year":"2016","journal-title":"Sleep Med. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jad.2016.03.016","article-title":"Bright light therapy for nonseasonal depression: Meta-analysis of clinical trials","volume":"198","author":"Jubair","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamapsychiatry.2015.2235","article-title":"Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: A randomized clinical trial","volume":"73","author":"Lam","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"17m11856","DOI":"10.4088\/JCP.17m11856","article-title":"Apetitive symptoms differentially predict treatment response to fluoxetine, light, and placebo in nonseasonal major depression","volume":"79","author":"Levitan","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.smrv.2017.12.001","article-title":"Revisiting the alerting effects of light: A systematic review","volume":"41","author":"Xu","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00406-015-0601-5","article-title":"Increased daylight availability reduces length of hospitalisation in depressive patients","volume":"266","author":"Mestre","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000477249","article-title":"Depressed patients hospitalized in southeast-facing rooms are discharged earlier than patients in northwest-facing rooms","volume":"74","author":"Gbyl","year":"2016","journal-title":"Neuropsychobiology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e12681","DOI":"10.1111\/jpi.12681","article-title":"Modeling melanopsin mediated effects of light on circadian phase, melatonin suppression, and subjective sleepiness","volume":"69","author":"Tekieh","year":"2020","journal-title":"J. Pineal Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/JAN.0000000000000049","article-title":"Lighting the darkness of addiction: Can phototerapy enhance contingence-management-based treatment of substance-related and addictive disorders?","volume":"25","author":"Siporin","year":"2014","journal-title":"J. Addict. Nurs."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Serrano-Serrano, A., M\u00e1rquez-Arrico, J.E., Navarro, J.F., Martinez-Nicolas, A., and Adan, A. (2021). Circadian characteristics in patients under treatment for substance use disorders and severe mental illness (schizophrenia, major depression and bipolar disorder). J. Clin. Med., 10.","DOI":"10.3390\/jcm10194388"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3389\/fphys.2019.01396","article-title":"Assessing chronotypes by ambulatory circadian monitoring","volume":"10","author":"Madrid","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36)","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"ref_67","unstructured":"Hasin, D.S., Trautman, K.D., Miele, G.M., Samet, S., Smith, M., and Endicott, J. (2021). Psychiatric Research Interview for Substance and Mental Disorders for DSM-5 (PRISM-5), Department of Psychiatry, Columbia University."},{"key":"ref_68","first-page":"35","article-title":"Validaci\u00f3n espa\u00f1ola del Drug Abuse Screening Test (DAST-20 y DAST-10)","volume":"10","year":"2010","journal-title":"Health Addict."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_70","first-page":"171","article-title":"Validaci\u00f3n de la escala de los s\u00edndromes positivo y negativo (PANSS) en una muestra de esquizofr\u00e9nicos espa\u00f1oles","volume":"22","author":"Peralta","year":"1994","journal-title":"Actas Luso-Espa\u00f1olas Neurol. Psiquiatr. Cienc. Afines"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0010-440X(89)90053-9","article-title":"Correlates of suicide and violence risk 1: The suicide risk measure","volume":"30","author":"Plutchik","year":"1989","journal-title":"Compr. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/07420528.2013.820740","article-title":"Circadian phase assessment by ambulatory monitoring in humans: Correlation with dim light melatonin onset","volume":"31","author":"Middleton","year":"2014","journal-title":"Chronobiol. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/bioengineering9020048","article-title":"Effect of short-term deep-pressure portable seat on behavioral and biological stress in children with autism spectrum disorders: A pilot study","volume":"9","author":"Afid","year":"2022","journal-title":"Bioengineering"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.6000\/2292-2598.2021.09.02.4","article-title":"The subjective comfort test of autism hug machine portable seat","volume":"9","author":"Maula","year":"2021","journal-title":"J. Intellect. Disabil. Diagn. Treat."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eurpsy.2005.01.003","article-title":"Reliability of the Spanish version of the Composite Scale of Morningness","volume":"20","author":"Adan","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Carissimi, A., Oliveira, M., Frey, B.N., Navarro, J.F., Hidalgo, M.P., and Adan, A. (2022). Validation and psychometric properties of the Spanish Mood Rhythm Instrument. Biol. Rhythm Res., in press.","DOI":"10.1080\/09291016.2019.1675023"},{"key":"ref_77","first-page":"59","article-title":"Propiedades psicom\u00e9tricas de la versi\u00f3n castellana del cuestionario de evaluaci\u00f3n de patr\u00f3n estacional (Seasonal Pattern Assessment Questionnaire, SPAQ)","volume":"38","author":"Adan","year":"2006","journal-title":"Rev. Latinoam. Psicol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(89)90013-9","article-title":"A visual analogue scale technique to measure global vigor and affect","volume":"27","author":"Monk","year":"1989","journal-title":"Psychiatry Res."},{"key":"ref_79","unstructured":"Wechsler, D. (2001). WAIS-III. Escala de Inteligencia Para Adultos de Wechsler, TEA Ediciones. [3rd ed.]."},{"key":"ref_80","first-page":"649","article-title":"Inventario de s\u00edntomas frontales para la evaluaci\u00f3n cl\u00ednica de las adicciones en la vida diaria: Proceso de creaci\u00f3n y propiedades psicom\u00e9tricas","volume":"54","year":"2012","journal-title":"Rev. Neurol."},{"key":"ref_81","first-page":"241","article-title":"Inventario de s\u00edntomas prefrontales (ISP): Validez ecol\u00f3gica y convergencia con medidas neuropsicol\u00f3gicas","volume":"63","year":"2016","journal-title":"Rev. Neurol."},{"key":"ref_82","unstructured":"Cloninger, C.R. (1999). The Temperament and Character Inventory-Revised, Center for Psychobiology of the Personality, Washington University."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1037\/0022-3514.65.4.757","article-title":"comparison of three structural models for personality: The Big Three, the Big Five, and the Alternative Five","volume":"65","author":"Zuckerman","year":"1993","journal-title":"J. Personality Soc. Psychol."},{"key":"ref_84","first-page":"324","article-title":"Spanish normative data of the Zuckerman-Kuhlman Personality Questionnaire in a general population sample","volume":"20","author":"Valero","year":"2008","journal-title":"Psicothema"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: A web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"(2013). World Medical Association WMA declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3109\/07420528.2010.516381","article-title":"Ethics and methods for biological rhythm research on animals and human beings","volume":"27","author":"Portaluppi","year":"2010","journal-title":"Chronobiol. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1001\/jama.286.18.2315","article-title":"Informed consent for population-based research involving genetics","volume":"286","author":"Beskow","year":"2001","journal-title":"JAMA"},{"key":"ref_89","unstructured":"World Health Organization (2021). Comprehensive Mental Health Action Plan 2013\u20132030, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240031029."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/wps.20796","article-title":"Managing dual disorders: A statement by the Informal Scientific Network, UN Commission on Narcotic Drugs","volume":"19","author":"Volkow","year":"2020","journal-title":"World Psychiatry"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/7\/1846\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:44:00Z","timestamp":1760136240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/7\/1846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":90,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["jcm11071846"],"URL":"https:\/\/doi.org\/10.3390\/jcm11071846","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]}}}